Using in vitro receptor activity studies of synthetic cannabinoids to support the risk assessment of new psychoactive substances – A Swedish strategy to protect public health from harm-Reference-Cited by-同舟云学术

Using in vitro receptor activity studies of synthetic cannabinoids to support the risk assessment of new psychoactive substances – A Swedish strategy to protect public health from harm

Published:2023-07 Issue: Volume:348 Page:111691
ISSN:0379-0738
Container-title:Forensic Science International
language:en
Short-container-title:Forensic Science International

Author:

Bäckberg Matilda^ORCID,Vikingsson Svante,Strandberg Joakim,Wall Sara,Åstrand Anna,Karlsson Hanna,Persson Mattias,Kronstrand Robert,Green Henrik

Funder

Folkhälsomyndigheten

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine,Law

Reference44 articles.

1. EMCDDA. European Drug Report 2019: Trends and Developments 〈https://www.emcdda.europa.eu/system/files/publications/11364/20191724_TDAT19001ENN_PDF.pdf〉. 2019.

2. EMCDDA. European Drug Report 2020: Trends and Developments. 2020. 〈https://www.emcdda.europa.eu/system/files/publications/13236/TDAT20001ENN_web.pdf〉.

3. EMCDDA. European Drug Report 2021: Trends and Developments. 2021. 〈https://www.emcdda.europa.eu/system/files/publications/13838/TDAT21001ENN.pdf〉.

4. EMCDDA. The European information system and database on new drugs (EDND) (login database). Accessed Jan 2023. 〈https://ednd2.emcdda.europa.eu/ednd/login〉.

5. Legal responses to NPS: multiple approaches to a multi-faceted problem (Special Segment);Glob. SMART Update Vol. 14,2015

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In vitro cannabinoid activity profiling of generic ban‐evading brominated synthetic cannabinoid receptor agonists and their analogs;Drug Testing and Analysis;2023-10-30